首页> 外国专利> NOVEL MONOMERS AND OLIGOMERS OF PEPTIDE NUCLEIC ACIDS

NOVEL MONOMERS AND OLIGOMERS OF PEPTIDE NUCLEIC ACIDS

机译:肽核酸的新单体和低聚物

摘要

FIELD: chemistry.;SUBSTANCE: invention relates to a compound of general formula (I): ; ;in which K is an active ester group of a carboxylic acid or -O-RM; where RM denotes an H atom, a methyl, ethyl, benzyl or tert-butyl group; Pr is an H atom or an amino-protecting group; # denotes asymmetric atom C; E is an adenine, cytosynyl, pseudo-isocytosynyl, guaninyl, thymine, uracilyl or phenyl group, optionally substituted with a protective group for the nucleotide base; R1 denotes a group of general formula (II):; ;in which R2 denotes a phosphonic ester group or a phosphonic acid group; R3 denotes an amino-protecting group; m is 1, 2, 3 or 4; and h denotes 0, 1, 2 or 3; provided that the sum of m and h in general formula (II) is within: 2≤x≤5. Also disclosed are a compound of formula (VI), such as specified in the patent claim, and a pharmaceutical composition.;EFFECT: disclosed compounds of formula (I) are novel monomers for producing oligomers of peptide nucleic acids of formula (VI), which can be used as a diagnostic agent or in antisense therapy.;10 cl, 7 dwg, 8 tbl, 24 ex
机译:化合物发明领域本发明涉及通式(I)的化合物: ;其中K是羧酸或-O-R M 的活性酯基;其中R M 表示H原子,甲基,乙基,苄基或叔丁基; Pr是H原子或氨基保护基。 #表示不对称原子C; E是腺嘌呤,胞嘧啶基,假异胞嘧啶基,鸟嘌呤基,胸腺嘧啶,尿嘧啶基或苯基,其任选地被核苷酸碱基的保护基取代; R 1 表示通式(II)的基团: ;其中R 2 表示膦酸酯基或膦酸基; R 3 表示氨基保护基; m为1、2、3或4; h表示0、1、2或3;通式(II)中m和h之和在2≤x≤5以内。还公开了如专利权利要求中所述的式(VI)的化合物和药物组合物。效果:公开的式(I)的化合物是用于产生式(VI)的肽核酸的低聚物的新型单体,可用作诊断剂或用于反义疗法。; 10 cl,7 dwg,8 tbl,24 ex

著录项

  • 公开/公告号RU2693827C2

    专利类型

  • 公开/公告日2019-07-05

    原文格式PDF

  • 申请/专利权人 UGISENSE AG;

    申请/专利号RU20160149427

  • 申请日2015-05-15

  • 分类号C07K14;C07D239/02;C07D239/42;C07D239/46;C07D473/18;C07D473/34;C12N15/113;A61K38/04;

  • 国家 RU

  • 入库时间 2022-08-21 11:46:05

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号